Insider · CIK 0001261156

KIRITSY CHRISTOPHER P

Reports to the SEC for 3 companies · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001261156

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−313 sh	—	—	0
2026-09-02	PVLAPALVELLA THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+313 sh	$127.20	+$39.8K	563
2026-09-02	PVLAPALVELLA THERAPEUTICS, INC.S Sale	Director	SSale	−313 sh	$157.00	−$49.1K	250
2026-06-10	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2025-06-10	PVLAPALVELLA THERAPEUTICS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,350
2024-12-13	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+24.7K sh	—	—	24,700
2024-12-02	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+500 sh	—	—	500
2023-06-21	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-05-25	PVLAPALVELLA THERAPEUTICS, INC.P Purchase	Director	PPurchase	+10K sh	$0.85	+$8,500	20,000
2022-09-15	HTG MOLECULAR DIAGNOSTICS, INCStock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2022-06-22	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2022-01-27	HTG MOLECULAR DIAGNOSTICS, INCStock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2021-06-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-23	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-23	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-09-14	PVLAPALVELLA THERAPEUTICS, INC.P Purchase	Director	PPurchase	+5,000 sh	$5.11	+$25.5K	10,000
2018-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-04-21	PVLAPALVELLA THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$1.59	+$7,950	5,000
2017-04-21	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	25,000
2017-01-25	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-09-20	PVLAPALVELLA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2005-05-20	KOS PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+5,000 sh	$19.50	+$97.5K	8,000
2005-05-20	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−5,000 sh	$55.00	−$275K	3,000
2005-05-20	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−5,000 sh	—	—	51,500
2005-05-16	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−9,000 sh	—	—	0
2005-05-16	KOS PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+8,500 sh	$19.50	+$166K	11,500
2005-05-16	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−1,000 sh	$53.65	−$53.7K	10,500
2005-05-16	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−7,500 sh	$53.00	−$398K	3,000
2005-05-16	KOS PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+9,000 sh	$12.97	+$117K	12,000
2005-05-16	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−9,000 sh	$53.65	−$483K	3,000
2005-05-16	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−8,500 sh	—	—	56,500
2005-05-13	KOS PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+2,500 sh	$12.97	+$32.4K	5,500
2005-05-13	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−2,500 sh	$53.00	−$133K	3,000
2005-05-13	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+2,500 sh	—	—	9,000
2005-02-01	KOS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Executive VP and CFO	AAward	+80K sh	—	—	80,000
2004-08-23	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−3,500 sh	$38.06	−$133K	2,640
2004-08-23	KOS PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+3,500 sh	$12.97	+$45.4K	6,140
2004-08-23	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−3,500 sh	—	—	21,500
2003-08-27	KOS PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+5,000 sh	$5.06	+$25.3K	7,097
2003-08-27	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−5,000 sh	—	—	8,000
2003-08-27	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−5,000 sh	$38.00	−$190K	2,097
2003-08-22	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−3,000 sh	—	—	0
2003-08-22	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−3,000 sh	$37.25	−$112K	2,097
2003-08-22	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−5,000 sh	$38.00	−$190K	5,097
2003-08-22	KOS PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+5,000 sh	$5.06	+$25.3K	10,097
2003-08-22	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−2,000 sh	—	—	13,000
2003-08-20	KOS PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−10K sh	$35.50	−$355K	5,097
2003-08-20	KOS PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−10K sh	—	—	3,000

Recent filings

Accepted (ET)
Sep 44
KIRITSY CHRISTOPHER P0001104659-26-105494
SEC(opens sec.gov)
Jun 124
KIRITSY CHRISTOPHER P0001104659-26-073443
SEC(opens sec.gov)
Jun 114
KIRITSY CHRISTOPHER P0001583648-25-000041
SEC(opens sec.gov)
Dec 174
KIRITSY CHRISTOPHER P0001062993-24-020815
SEC(opens sec.gov)
Dec 94
KIRITSY CHRISTOPHER P0001437749-24-036916
SEC(opens sec.gov)
Jun 234
KIRITSY CHRISTOPHER P0001437749-23-018281
SEC(opens sec.gov)
May 304
KIRITSY CHRISTOPHER P0001562180-23-004575
SEC(opens sec.gov)
Sep 154
KIRITSY CHRISTOPHER P0001209191-22-050150
SEC(opens sec.gov)
Jun 244
KIRITSY CHRISTOPHER P0001583648-22-000050
SEC(opens sec.gov)
Jan 314
KIRITSY CHRISTOPHER P0001209191-22-005588
SEC(opens sec.gov)
Jun 294
KIRITSY CHRISTOPHER P0001562180-21-004561
SEC(opens sec.gov)
Jun 254/A
KIRITSY CHRISTOPHER P0001562180-20-004696
SEC(opens sec.gov)
Jun 254
KIRITSY CHRISTOPHER P0001562180-20-004689
SEC(opens sec.gov)
Jan 284
KIRITSY CHRISTOPHER P0001562180-20-000621
SEC(opens sec.gov)
Jan 294
KIRITSY CHRISTOPHER P0001562180-19-000577
SEC(opens sec.gov)
Sep 174
KIRITSY CHRISTOPHER P0001562180-18-003953
SEC(opens sec.gov)
Jan 294
KIRITSY CHRISTOPHER P0001562180-18-000484
SEC(opens sec.gov)
May 94
PIERIS PHARMACEUTICALS, INC.0000899243-17-012544
SEC(opens sec.gov)

Companies

Address

C/O PALVELLA THERAPEUTICS, INC. 353 W. LANCASTER AVENUE, SUITE 200

WAYNE, PA, 19087